ArticleCaspian journal of internal medicine2021

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study.

Rozita Doosti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.